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Abstract: 
 
Background and Aims: 
Patients undergoing restorative proctocolectomy (RPC) have often suffered from active 
ulcerative colitis (UC) which should be remembered when assessing quality of life after 
operation.  
The aim of this study was to explore health-related quality of life (HRQoL) after RPC in those 
with poor or good pouch function, and to compare that to patients with active or inactive UC 
and to the general population.    
Material and Methods:  
Altogether 282 RPC patients were investigated. The control group comprised 408 UC patients 
from the local register. Generic 15D and disease-specific IBDQ HRQoL instruments were used. 
Population-based data were available for 15D. Pouch function was evaluated with Öresland 
score and colitis activity with Simple clinical colitis activity index.  
Results: 
15D results showed that patients with good pouch function had HRQoL similar to that of 
general population. HRQoL with IBDQ was equally good in patients with good pouch function 
(n =131; 70%) and inactive colitis (95; 63%), and equally impaired in patients with poor pouch 
function (56; 30%) and active colitis (18; 12%).  
Conclusions: 
The majority of patients had HRQoL comparable to that in general population. Most patients 
with active UC are likely to improve their HRQoL after successful surgery. These findings 
are important when informing colitis patients about life after surgery. 
 
Keywords: quality of life, restorative proctocolectomy, IPAA, ulcerative colitis, 15D-
instrument, IBDQ
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Introduction 
 
 Restorative proctocolectomy (RPC) is the standard operation for patients with active 
ulcerative colitis (UC) (1). With successful surgery, patients can avoid a permanent stoma, 
and are able to live a normal life. Health-related quality of life (HRQoL) is essential in 
evaluating the long-term results of the operation, since RPC may be associated with 
complications and functional failures  (2, 3).  
Many studies have shown that HRQoL in RPC patients has been comparable to that in general 
population  (4-6). On the other hand, poor functional results are associated with impaired 
quality of life, (7-9) which again may influence these patients’ daily lives. It must be noted 
that patients undergoing RPC usually suffer from active colitis and HRQoL after the 
operation is important in this group. 
Here we compared results separately to non-operated colitis patients with active or inactive 
disease and similarly in RPC patients with good or poor functional result. This information 
about functional outcome and quality of life is valuable when the physician is discussing 
surgical treatment with the patient.
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Material and Methods 
 
Patient selection 
This cross-sectional study included all consecutive 352 patients with UC who 
underwent RPC at Tampere University Hospital between 1985 and 2009; the subjects 
were identified in the hospital records using the ICD-9 and ICD-10 codes for UC and 
official codes for the operations performed. A database to form a RPC registry was 
collected from patient files including details on patient history, operation technique, 
postoperative morbidity, and follow up. Of these, 282 had their pouch in function and 
could be located and they were sent questionnaires. Data were collected between 
October 2012 and May 2013. The control group consisted of 408 age and sex matched 
UC patients from the local inflammatory bowel disease (IBD) register. It is a 
prospective register for all adult patients with IBD. Cases were collected retrospectively 
before 1986 and after that prospectively. The age and gender distributions of the study 
group and the control group were similar. See the selection path for the groups in Table 
1. The clinical data of the study patients is retrieved from these registries mentioned 
above.  
 
Questionnaires 
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The questionnaires were sent by mail and one reminder was sent to the non-
respondents. Two different instruments were used to measure HRQoL; one generic 
(15D) and one disease-specific (IBDQ).  Pouch function was assessed by Öresland 
score  (10) and disease activity in non-operated subjects with UC by simple clinical 
colitis activity index (SCCAI) (11).  The 15D instrument is Finnish and the other 
questionnaires were translated from English into Finnish by official translators and a back-translation into English was done to confirm the linguistic accuracy of the translation. 
The 15D is a generic self-administered measure of HRQoL. The instrument can be used 
both as a profile and as a single score measure. The questionnaire includes 15 
dimensions: mobility, vision, hearing, breathing, sleeping, eating, speech, excretion, 
usual activities, mental function, discomfort and symptoms, depression, distress, vitality 
and sexual activity. For each dimension, respondents choose one of the five ordinal 
levels best describing their current state of health. The valuation system is based on an 
application of multi-attribute utility theory. The single index score (15D score), 
reflecting overall HRQoL on a 0-1 scale (1=full health, 0=being dead) and similarly, the 
dimension level values, reflecting the goodness of the levels relative to no problems on 
the dimension (=1) and to being dead (=0), were calculated from the questionnaire using 
a set of population-based preference or utility weights. Mean dimension level values 
were used to draw 15D profiles. A difference of ≥ 0.03 in 15D score was considered 
 7 
 
7 
clinically important in the sense that a person can, on average, feel the difference  (12). 
The 15D has been used with IBD patients before  (13). The 15D data for general 
population came from the National Health 2011 Survey representing Finnish population 
aged 18 and over. This sample (n=4763) was weighted to reflect the age and gender 
distribution of the patients  (14). 
A disease-specific IBDQ is a widely used standardized 32-item questionnaire, which 
addresses four different aspects of life: digestive symptoms, social functioning, 
emotional status and systemic symptoms. The questionnaire has been validated in 
patients undergoing RPC for UC  (15). It has been translated into Finnish and used in 
IBD  (16). Total IBDQ score ranges from 32 to 224, a higher score indicating better 
quality of life.  
 Pouch function was assessed by Öresland score  (10). It includes items about the 
number of day-time and night-time bowel movements, incontinence for liquid or solid 
stools, pad usage, urgency, diet, medication and social handicap; these ratings are 
summarized into a single score (range 0-15; 15 being worst). The questionnaire was 
translated into Finnish and was used with the permission of the developer  (10). This 
questionnaire has been tailored for RPC, and used in previous studies to elicit pouch 
function and HRQoL in UC. In the study by Berdtson et al., poor Öresland scores 
correlated negatively with HRQoL results. The authors classified the score indicating 
very good (0-4), good (5-7) or poor pouch function (8-15). We decided to combine the 
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groups with very good and good pouch function and hence the limit was set at a score of 
8.  
Disease activity of UC was measured using the Simple clinical colitis activity index 
(SCCAI)  (11). A score of ≤ 2 was defined as remission, 3 to 4 as mild or moderately 
active disease, and ≥ 5 as severely active disease  (17, 18). 
 
Statistics 
The data were analyzed using SPSS (IBM Corp. Released 2012. IBM SPSS Statistics 
for Windows, Version 21.0. Armonk, NY: IBM Corp).  
The 15D index was chosen to be the main parameter with which the power calculations 
were made in the planning phase. With 15D difference ≥ 0.03 can be detected by an 
individual  (19). Power calculations have been made using PS program difference being 
0.03, power 80% and statistical difference 0.05. In this way both groups need to include 
142 patients.  
For categorical variables the results are given as frequencies and percentages, for 
continuous variables as means and standard deviation, or as medians. Comparisons 
between different patient groups were tested with chi square test and in IBDQ scores 
with Kruskal-Wallis test. Independent samples t-test was used to compare the mean 15D 
scores of the patients and the age- and gender-standardized sample of general 
population. P-values ≤ 0.05 were considered statistically significant.  
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Results 
The gender distribution of the respondents were 47% of women in both the study and 
the control groups. The median age was 53 years in the study group and 55 years in the 
control group. The demographic data on both groups for responders and non-responders 
are shown in Table 2.  
 
RPC patients 
Of the 352 patients operated on between 1985 and 2009, pouch failure (pouch excision 
or permanent ileostomy without excision) had occurred in 42 and were excluded, three 
could not be reached and 25 had died (Table 1.). Of the eligible 282 patients, 187 
(66.3%) returned the questionnaires; 87 (67%, n=130) of the women and 100 (66%, 
n=152 66%) of the men. The median age of the patients was 53 years (range 23-81) and 
the median follow-up time after RPC was 13 years (range 4-28).  
The 95 RPC patients who did not return the questionnaire were on average three and a 
half years younger than those who did respond; there was no gender difference between 
respondents and non-respondents. When we compared the clinical data conserning the 
operation, we found that there was no significant difference in leakage or pelvic sepsis 
between the respondents and non-respondents. 
Altogether 131 (70%) of the patients had a well-functioning pouch with a score of < 8, 
and 56 (30%) a poor pouch function.  
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UC patients 
In non-operated UC patients, 153 (37.5%) out of 408 returned the questionnaire (72 
women, 84 men, 47% women). The median age of the patients was 55 years (range 24-
81). Of the non-operated UC patients 95 (62.1%) were in remission, 39 (25.5%) had 
mild to moderately active disease and 18 (11.8%) severely active, as defined by SCCAI. 
 
15D scores 
The mean 15D score of the RPC patients undergoing surgery was lower 0.891 (0.097) 
than that of general population 0.928 (0.077) (p<0.001). The RPC patients scored 
statistically significantly lower on 8 out of the 15 dimensions compared to the age-and 
gender-standardized sample of general population: sleeping, usual activities, excretion, 
discomfort and symptoms, depression, distress, vitality and sexual activity (Fig 1a). In 
RPC patients with well-functioning pouches, the only significantly decreased score was 
in excretion (Fig 1b). 
 
IBDQ scores 
Fig. 2a shows that HRQoL was equally good in patients with good pouch function and 
inactive UC when measured by disease-specific IBDQ, and also equally impaired in 
those with poor pouch function and active UC.  
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The IBDQ subscores for the different groups are presented in Table 3.   
Patients with good pouch function showed better results in all subscores than those with 
active colitis (p < 0.001). There was no difference between groups when divided by the 
indication for surgery (p = 0.135-0.850).   
The IBDQ scores for subgroups of different indications for patients undergoing surgery 
compared to ulcerative colitis of different disease activity are shown in Fig. 2b. Fig. 2c 
shows the IBDQ scores of operated patients with different time from operation.  
There was no difference in HRQoL after surgery in different indications or time from 
operation. The scores were lower for RPC patients for any indication for surgery or time 
from operation than UC patients in remission, but higher than UC patients with active 
disease.  
  
 13 
 
13 
  Discussion 
 
This study investigated HRQoL using generic (15D) and disease-specific (IBDQ) 
questionnaires in a large cohort of patients operated on at a single institution within a 
period spanning over two decades. The main finding of this study was that RPC patients 
with a well-functioning pouch achieved HRQoL similar to that in general population 
and UC patients with their disease in remission or mild to moderate activity.  
HRQoL has previously been reported to improve after RPC and reach the level of that 
in general population,  (4-6) although the results are inconsistent  (20, 21). In a recent 
Finnish multicentre study HRQoL was impaired compared to the general population. 
This study also aimed to identify factors for poor outcome and found older age at time 
of operation and preoperative hypertension to be significant predictors (22).  In the 
present study, most (131, 70.1%) of the RPC patients had well-functioning pouch. Well-
functioning pouch was associated with good HRQoL and therefore, the majority of RPC 
patients were satisfied with their lives after surgery. Poor functional results of the pouch 
have been associated with low HRQoL  (7-9, 23). This was also shown in this study. 
This is something about which we can inform the patients preoperatively even though 
we do not know the reliable risk factors to identify patients prone to poor pouch 
function or pouch failure before surgery  (24, 25). 
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UC patients with only mildly active disease, or the disease in remission reported quality 
of life equally as good as that of RPC patients with well-functioning pouch. 
 The quality of life scores were equally poor in patients with poorly functioning pouch 
or severely active UC.  An Italian study showed similar results: UC in remission 
showed an overall QoL similar to that of uncomplicated RPC patients, while the same 
two groups of patients with mild clinical activity had an overall QoL score similar to 
those of patients with complicated RPC  (26). A recent study also showed that even 
though RPC patients reported higher bowel movement frequency than patients treated 
with anti-TNF (tumor necrosis factor), the RPC patients reported better outcomes for 
general HRQoL  (27).   
The patients who are considered for operative treatment are those with active acute 
severe colitis or medically refractory disease or those with dysplasia or cancer. There 
was no difference in HRQoL when comparing study patients divided by indication. But 
as we can see in Fig. 3, patients in remission undergoing surgery due to dysplasia or 
cancer were likely to experience deterioration in HRQoL, whereas patients operated on 
for active disease experience an improvement in HRQoL after successful surgery. For 
dysplasia patients we should emphasize the fact that with surgical treatment potentially 
life-threatening disease will be treated, and yet one can in most cases perform ileal 
pouch surgery with moderately good and stable HRQoL without permanent ileostomy.  
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The long-term results are important, since most of the patients undergoing surgery are 
young; the median follow-up time of 13 years in this study (range 4-28) gives a good 
perspective on this. Quality of life was not dependent on the time elapsing since the 
operation.  
A limitation of this study was the large number of patients who did not return the 
questionnaires. Response rates have declined in Finland in recent decades both in men 
and women in all age groups, faster among men and in younger age groups  (28). The 
non-response rate was high especially in non-operated UC. Nevertheless, it was possible 
make comparisons between patients with active and inactive UC, as we had enough 
patients in each activity group. Furthermore, there was no gender difference between 
operated and non-operated colitis patients, and the median age was almost the same. For 
comparison, in the entire colitis register, 45% were women, i.e. the same percentage as 
in this study. The non-responders in RPC group were three years younger than the 
responders. Although younger patients have had slightly better functional results, we 
assume that this small difference did not influence the results significantly. Pelvic 
inflammatory complications may impair the functional outcome  (29, 30). The 
respondents and non-respondents did not differ in leakage or pelvic sepsis. Therefore 
we assume that the functional result that we used on dividing the RPC groups was valid. 
We did not investigate RPC patients who had experienced pouch failure. It would have 
not been possible to study the HRQoL before and after the pouch failure, which we 
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think would have given the full picture. We did not include the patients undergoing 
permanent ileostomy. The number of such patients was low, including mostly elderly 
patients with a poor sphincter function, and do not have RPC as an option.  We did not 
have individual information about pre- and postoperative HRQoL. However, the results 
of our study show the same trend as studies with preoperative HRQoL data of how 
HRQoL improves after surgery  (4, 6). 
In conclusion, this study showed that successful RPC surgery for UC affords the 
majority of patients good and stable functional results. This again enables good long-
term HRQoL, being comparable to that in the general population and in UC patients in 
remission. In the case of poor pouch function, quality of life remains at the same level 
to that in active UC. On the other hand, the surgery removes the disease carrying colon, 
eliminating several risks, such as bleeding or cancer development, and in most patients 
burdensome and expensive medications can be discontinued. Nevertheless, our results 
are important when counseling the patients before the operation.  
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Figure Legends 
Fig 1 15D scores of all restorative proctocolectomy patients with ileal pouch (n=187) 
compared to general population n=4762 (1a); scores for well-functioning pouches (n=131) in 
comparison to the population are depicted separately in 1b.   
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Fig 2  
IBDQ total scores in different subgroups of patients with ileal pouch or ulcerative colitis (UC) 
compared to non-operated patients for different disease activity groups.  The score limits for 
each subgroup have been described in the methods section; pouch function was measured by 
Öresland score and the activity of colitis by SCCAI score. 
2a. IBDQ total scores for good and poor functioning pouches. 
2b. IBDQ total scores in different subgroups of indication for surgery. 
2c. IBDQ total scores on subgroups on how much time had past since operation.  
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